Mr. Cline brings extensive commercial expertise to lead the transition of Xenon to a commercial-stage company with the anticipated launch of azetukalner across three potential indicationsVANCOUVER, ...

Roche is taking on Alexion’s blockbuster Soliris (eculizumab ... Uplinza (inebilizumab). The big Swiss pharma had been hoping for approval in patients regardless of whether they have anti ...